Eminence Biotechnology Co., Ltd. reported that its state-of-the-art facility for the commercial production of cell culture media is fully operational. The opening aims to address the rapidly growing demand for high-quality media in the fields of vaccines, gene therapies, cell therapies, antibodies, and recombinant proteins. The new facility, at the BIOBAY Phase II, Suzhou Industrial Park, occupies approximately 7,000 square meters and comprises dedicated zones for media production, warehousin...